首页> 外国专利> RECOMBINANT PLASMID DNA pFK2 PROVIDING SYNTHESIS OF RECOMBINANT PEPTIDE BEING HUMAN KAPPA CASEIN FRAGMENT ANALOGUE, METHOD FOR PREPARING RECOMBINANT PEPTIDE, AND RECOMBINANT PEPTIDE, HUMAN KAPPA CASEIN FRAGMENT ANALOGUE EXHIBITING APOPTOTIC ACTIVITY IN RELATION TO MALIGNANT CELLS

RECOMBINANT PLASMID DNA pFK2 PROVIDING SYNTHESIS OF RECOMBINANT PEPTIDE BEING HUMAN KAPPA CASEIN FRAGMENT ANALOGUE, METHOD FOR PREPARING RECOMBINANT PEPTIDE, AND RECOMBINANT PEPTIDE, HUMAN KAPPA CASEIN FRAGMENT ANALOGUE EXHIBITING APOPTOTIC ACTIVITY IN RELATION TO MALIGNANT CELLS

机译:重组质粒DNA pFK2提供了人κ酪蛋白片段类似物的重组肽,制备重组肽的方法,以及人κ酪蛋白片段类似物表达了凋亡力的重组肽。

摘要

FIELD: medicine.;SUBSTANCE: invention can be used in medical and biologic industry for preparing antineoplastic drugs. Plasmid DNA pFK2 providing synthesis of recombinant analogue of human kappa casein fragment, in Escherichia coli cells is designed; and a method for preparing a recombinant product with using it is described. The recombinant analogue of human kappa-casein fragment recovered from Escherichia coli cells transformed by recombinant plasmid DNA pFK2 has molecular weight of approximately 16 kDa; consists of residual methionine, human kappa-casein fragment with 24 on 134 amino acid residue and C-terminal histidine path and exhibits apoptotic activity in relation to malignant cells.;EFFECT: higher anticancer activity of the compounds.;3 cl, 6 dwg, 4 ex
机译:领域:药物;物质:本发明可用于医学和生物工业中以制备抗肿瘤药。设计了质粒DNA pFK2,其在大肠杆菌细胞中合成人κ酪蛋白片段的重组类似物;本发明还描述了使用该方法制备重组产物的方法。从重组质粒DNA pFK2转化的大肠杆菌细胞中回收的人κ-酪蛋白片段的重组类似物的分子量约为16kDa。由残留的蛋氨酸,具有134个氨基酸残基的24个C端组氨酸路径的人Kappa-酪蛋白片段组成,并相对于恶性细胞具有凋亡活性;效果:该化合物具有更高的抗癌活性; 3 cl,6 dwg, 4前

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号